ALLMedicine™ Deep Vein Thrombosis Center

Oct 23rd, 2021 - Stroke is the third leading cause of early death worldwide. Most ischaemic strokes are caused by a blood clot blocking an artery in the brain. Patient outcomes might be improved if they are offered anticoagulants that reduce their risk of developi...

Oct 23rd, 2021 - Charcot neuroarthropathy (CN) is an inflammatory arthropathy associated with bony destruction, dislocation, and deformity in patients with neuropathy. Surgical procedures involving foot and ankle in CN for deformity correction have been shown to r...

Oct 22nd, 2021 - This is a study to learn more about French patients who have peripheral artery disease (PAD) and who have had a revascularization procedure. With this procedure, doctors use surgery or a thin tube (called a catheter) to open a narrow or blocked bl...

Oct 22nd, 2021 - To assess the validity of Caprini risk assessment model(RAM) in risk stratification for deep vein thrombosis (DVT) and to investigate the diagnostic value of Caprini score combined with D-dimer in predicting DVT. This study involved 429 patients w...

Oct 20th, 2021 - Comatose survivors of out-of-hospital cardiac arrest experience high rates of death and severe neurologic injury. Current guidelines recommend targeted temperature management at 32 °C to 36 °C for 24 hours. However, small studies suggest a potenti...

Oct 3rd, 2020 - Venous thromboembolism (VTE), which includes deep vein thrombosis (DVT) and pulmonary embolism (PE), occurs in ∼1 to 2 individuals per 1000 each year, corresponding to ∼300 000 to 600 000 events in the United States annually. These evidence-based ...

May 7th, 2020 - This publication includes the appropriate imaging modalities to assess suspected deep vein thrombosis in the upper extremities. Ultrasound duplex Doppler is the most appropriate imaging modality to assess upper-extremity deep vein thrombosis. It i...

May 7th, 2020 - Iliofemoral venous thrombosis carries a high risk for pulmonary embolism, recurrent deep vein thrombosis, and post-thrombotic syndrome complicating 30% to 71% of those affected. The clinical scenarios in which iliofemoral venous thrombosis is mana...

May 6th, 2019 - Venous thromboembolism (VTE)-deep vein thrombosis and pulmonary embolism-is a common cause of morbidity and mortality. The mainstay of VTE prophylaxis and therapy is anticoagulation. In select patients with VTE, inferior vena cava (IVC) filters ar...

Nov 6th, 2018 - Suspected lower extremity deep venous thrombosis is a common clinical scenario which providers seek a reliable test to guide management. The importance of confidently making this diagnosis lies in the 50% to 60% risk of pulmonary embolism with unt...

Oct 22nd, 2021 - This is a study to learn more about French patients who have peripheral artery disease (PAD) and who have had a revascularization procedure. With this procedure, doctors use surgery or a thin tube (called a catheter) to open a narrow or blocked bl...

Oct 15th, 2021 - The primary objective is to compare the safety of edoxaban with the standard of care (SOC) in pediatric subjects with cardiac diseases at risk of thromboembolic complications who need primary or secondary anticoagulant prophylaxis with regard to t...

Oct 11th, 2021 - Major surgery is a serious physiological condition that can cause significant morbidity and mortality. Adverse conditions encountered during major surgery may be fatal, cause one or more postoperative complications, negatively affect short-term an...

Oct 11th, 2021 - Venous thromboembolic disease (VTE) is a common clinical entity whose two manifestations are deep vein thrombosis (DVT) and pulmonary embolism (PE). After an acute PE, almost half of the patients complain residual dyspnea, despite well-conducted c...

Oct 11th, 2021 - Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), first identified in Wuhan, China in December of 2019, has become a worldwide pandemic with widespread illness and mortality. Clinical manifestations of Coronavirus disease 2019 (COVID-1...

Oct 6th, 2021 - Alok A. Khorana, MD Investigators at Cleveland Clinic have demonstrated that the direct oral anticoagulant rivaroxaban (Xarelto) significantly reduces venous thromboembolism (VTE) and VTE-related death for patients with high-risk cancers treated ...

Oct 6th, 2021 - Katherine C. Rappazzo, MD Jennifer R. Green, MD Assistant Professor of Medicine, Director of the Vanderbilt Hemophilia/ Hemostasis Treatment Clinic, Vanderbilt University Medical Center, Nashville, Tennessee In the treatment of acut...

Oct 6th, 2021 - Perry Shen, MD, FACS Clancy Clark, MD Wake Forest Baptist Health Comprehensive Cancer Center Despite an overall decline in cancer death rates during the last decade, hepatic and pancreatic cancer death rates are on ...

Oct 6th, 2021 - Sunil R. Hingorani, MD, PhD The addition of the enzyme PEGPH20 to standard nab-paclitaxel and gemcitabine improved progression-free survival (PFS) by 4.9 months compared with the two agents alone in untreated patients with advanced pancreatic can...

Oct 6th, 2021 - Miguel Perales, MD CAR T-cell therapy has emerged as a promising therapy for select patients with non-Hodgkin lymphoma (NHL), but as research continues and the treatment is used in a real-world setting, overarching guidelines must be set in place...